Who
Heather C. Getz
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, TELA Bio; Director, Myomo; EVP, CFO & COO, Butterfly Network; EVP, CFO & CAO, Biotelemetry; Chief Financial Officer, CardioNet.
In numbers
- Trades disclosed
- 130
- Buys
- 4
- Sells
- 30
- Bought
- $168K
- Sold
- $14.3M
- Companies
- 5
- Companies where not an officer
- 1
- First trade
- 21 Jan 2010
- Last trade
- 17 Aug 2026
- Last filed
- 19 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 19 Aug 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $8,31112,500 at $0.6649 | filing |
| 17 Aug 2026filed 19 Aug 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $8,25012,500 at $0.66 | filing |
| 14 Aug 2026filed 17 Aug 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $10K15,000 at $0.6978 | filing |
| 14 Aug 2026filed 17 Aug 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $11K15,000 at $0.70 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —1,365,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —1,005,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —1,365,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —1,005,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 25 Jun 2026filed 26 Jun 2026 | MYO MyomoMedical Devices | SEC FORM 4 Code A | —78,704 at $0.00 | filing |
| 25 Jun 2026filed 26 Jun 2026 | MYO MyomoMedical Devices | SEC FORM 4 Code A | —78,704 at $0.00 | filing |
| 16 Mar 2026filed 17 Mar 2026 | MYO MyomoMedical Devices | SEC FORM 4 Bought | $14K20,000 at $0.6986 | filing |
| 16 Mar 2026filed 17 Mar 2026 | MYO MyomoMedical Devices | SEC FORM 4 Bought | $14K20,000 at $0.70 | filing |
| 12 Mar 2026filed 12 Mar 2026 | MYO MyomoMedical Devices | SEC FORM 4 Bought | $51K70,000 at $0.728 | filing |
| 12 Mar 2026filed 12 Mar 2026 | MYO MyomoMedical Devices | SEC FORM 4 Bought | $51K70,000 at $0.73 | filing |
| 11 Jun 2025filed 12 Jun 2025 | MYO MyomoMedical Devices | SEC FORM 4 Code A | —29,720 at $0.00 | filing |
| 5 May 2025filed 7 May 2025 | BFLY Butterfly NetworkMedical Devices | SEC FORM 4 Sold | $144K65,456 at $2.20 | filing |
| 3 Mar 2025filed 4 Mar 2025 | BFLY Butterfly NetworkMedical Devices | SEC FORM 4 Code F | $856K282,649 at $3.03 | filing |
| 1 Mar 2025filed 4 Mar 2025 | BFLY Butterfly NetworkMedical Devices | SEC FORM 4 Code A | —569,211 at $0.00 | filing |
News
TELA Bio (NASDAQ:TELA) versus Shoulder Innovations (NYSE:SI) Head to Head SurveyTELA · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Heather C. Getz; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.